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Summary In situ hybridization on human colon tissue demonstrates that epidermal growth factor receptor (EGFR) mRNA expression is
strongly increased during tumour progression. To obtain test systems to evaluate the relevance of growth factor action during carcinogenesis,
primary cultures from human colorectal carcinomas were established. EGFR distribution was determined in 2 of the 27 primary cultures and
was compared with that in well-defined subclones derived from the Caco-2 cell line, which has the unique property to differentiate
spontaneously in vitro in a manner similar to normal enterocytes. The primary carcinoma-derived cells had up to three-fold highertotal EGFR
levels than the Caco-2 subclones and a basal mitotic rate at least fourfold higher. The EGFR affinity constant is 0.26 nmol 1-1, which is similar
to that reported in Caco-2 cells. The proliferation rate of Caco-2 cells is mainly induced by EGF from the basolateral cell surface where the
majority of receptors are located, whereas primary cultures are strongly stimulated from the apical side also. This corresponds to a three- to
fivefold higher level of EGFR at the apical cell surface. This redistribution of EGFR to apical plasma membranes in advanced colon carcinoma
cells suggests that autocrine growth factors in the colon lumen may play a significant role during tumour progression.
Keywords: EGFR redistribution; human colorectal tumour progression; primary culture; polarized EGF response; autocrine growth control
Epidermal growth factor (EGF) and transforming growth factor
alpha (TGF-a) have been implicated in growth regulation of a
variety of cells by binding to a common cell membrane receptor
(EGFR). The EGFR is a transmembrane glycoprotein with tyro-
sine-specific protein kinase activity that activates multiple signal
transduction pathways. Recently, evidence has been provided
suggesting that EGFR and its ligands, possibly by autocrine mech-
anisms, are important regulators of proliferation in both normal
tissue and many types of tumours (Khazaie et al, 1993). For
instance, transfection to achieve co-expression of TGF-a and
EGFR results in transformation of fibroblast cell lines (Di Marco
et al, 1989). Although TGF-a expression has also been detected in
normal colon (Malden et al, 1989), co-expression of TGF-a and
EGFR andgrowth stimulation by TGF-ahas been demonstrated in
multiple colon cancer cell lines (Mulder and Brattain, 1989).
Overexpression of EGFR has been reported in squamous cell
carcinoma of the skin, oesophagus (Itakura et al, 1994; Stanton
et al, 1994), non-small-cell lung carcinoma (Rusch et al, 1993),
breast adenocarcinoma and endometrial adenocarcinoma (Khalifa
et al, 1994; Miller et al, 1994). In colon cancer it has been well
documented that overexpression of EGFR may indicate an
advanced stage of the disease (Gross et al, 1991) and may predict
the metastatic potential (Radinsky et al, 1995). These data indicate
that the EGF or TGF-a-activated growth regulatory system may
play a significant role during colorectal carcinogenesis, possibly
via increased EGFR expression. It is also well known that the
EGFR is mainly present at the basolateral and not the apical
luminal side in normal human enterocytes (Playford et al, 1995).
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Expression and distribution of the receptor during human colon
tumour progression, however, is unknown up to now.
To study mechanisms of hyperplastic growth during human
colorectal tumour progression, in vitro experimental systems are
essential. Establishment of primary cultures from human
colorectal carcinomas and derivation of cell lines therefrom were
attempted by several groups, and some systems have been
described (see, for example, Friedman, 1989; Paraskeva et al,
1989; Paraskeva and Hague, 1991). However, an effective method
allowing routine cultivation of primary cells and early passaged
cells has been lacking up to now.
In this report, we present a reproducible method to obtain
primary cultures from human colorectal carcinomas, which were
used to study EGFR distribution on apical and basolateral cell
membranes and growth responses of early passaged primary cells
grown on filter units. Human colon adenocarcinoma-derived
Caco-2 cells were studied in comparison because these cells,
despite their malignant origin, are still able to differentiate sponta-
neously in culture, acquiring morphological and functional charac-
teristics ofnormal enterocytes and thus are widely used as a model
system in studies of normal intestinal cell functions (Pinto et al,
1983). Our results suggest that during development of colorectal
cancer (a) EGFR expression in tumour cells conspicuously
increases, and (b) inasmuch as EGF-binding sites are redistributed
from the basolateral to the apical cell surface, a typical oncofetal
pattern ofEGFR polarity is attained.
MATERIALS AND METHODS
Materials
Dulbecco's modified Eagle medium (DMEM) with 4.5 g 1-1
glucose, penicillin, streptomycin, nystatin, gentamycin, N-hydroxy-
ethyl-piperazine-N'-2-ethane sulphonic acid (Hepes) and fetal calf
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serum (FCS) were from Gibco BRL, UK. Hydrocortisone, sodium
selenite, insulin, transferrin, collagenase (type IV) were from
Sigma, Deisenhofen, Germany. Dispase (grade I) was obtained
from Boehringer Mannheim, Germany. BCA protein assay kit was
from Pierce, Rockford, IL, USA. All tissue culture plasticware was
from Becton Dickinson Labware, Bedford, CA, USA.
Patient material
Patient tissue was obtained from the Clinic of Surgery, University
of Vienna General Hospital, and the Department of Surgery,
Kaiserin Elisabeth Hospital, Vienna. Consent from the Ethics
Commission of the University of Vienna Medical School was
obtained before experiments.
Primary colon carcinomas (well or moderately differentiated) as
well as normal tissue from outside the tumour border were
obtained from five patients and used for in situ hybridization
(ISH). A total of 45 primary colorectal carcinomas (well, moder-
ately and poorly differentiated) were used to establish primary
cultures.
Primary cultures
For establishment of primary cultures all types of tissue were
processed within 1-2 h of surgery. Briefly, specimens were exten-
sively washed and finely minced into 1-mm pieces. Thereby,
single cells as well as cell clumps (organoids) are released into the
washing medium. Large clumps can be separated by allowing to
settle for a few minutes under gravity force. They can be further
reduced in size by gentle rotation in a test tube for 30-60 min.
Cells and cell clumps isolated in this way can be directly used for
primary cultures. Tissue pieces were also subjected to enzymatic
digestion with 0.3 mg ml-' collagenase and 0.8 U ml-1 dispase by
gentle agitation for 1-2 hours at 37°C in DMEM containing 5%
FCS, 200 U ml-' penicillin, 200 ,ug ml-' streptomycin, 50 jg ml-'
gentamycin and 50 U ml-' nystatin.
Isolated cells and organoids were routinely seeded onto round
glass coverslips in growth medium containing 10% FCS,
10 mmol l-1 Hepes, 4.0 mmol 1-1 glutamine, 100 U ml-' penicillin,
100 jig ml-' streptomycin, 50 jg ml-' gentamycin, 50 U ml-'
nystatin, 1 jig ml-' hydrocortisone, 0.2 U ml-' insulin, 2 jig ml-'
transferrin, and 5 nmol 1-1 sodium selenite. They were incubated at
37°C in a humidified atmosphere of 95% air and 5% carbon
dioxide. Dishes were left undisturbed for 5-7 days and subsequent
feeding was carried out on a biweekly schedule. Fibroblast over-
growth was controlled by using human foreskin 3T3 fibroblasts
lethally irradiated with 60 Gy (6000 rads) of gamma-radiation
(ILB-437C, CIS Biointernational, France) as feeder layer. Feeder
layers were used at 30-40% confluency and were maintained for 1
week. Alternatively 3T3 culture supernates were mixed 1:1 with
fresh growth medium (conditioned growth medium). For initial
passaging, primary cultures were subcultured only when areas of
tumour cell growth became confluent. For the first two passages
all cells from a coverslip were mechanically scraped offand trans-
ferred to a fresh culture plate with conditioned growth medium.
Normally, after the third passage enough primary cells could be
obtained for EGFR measurement. Cellular morphology in all
cultures was evaluated by light microscopy after Giemsa staining.
Epithelial nature was characterized with monoclonal antibodies
against cytokeratin 8 and 18.
Electron microscopy
For transmission electron microscopy (TEM) cells were grown on
coverslips. After a short rinse in cacodylate buffer and fixation for
2 h in 2.5% glutaraldehyde, post-fixation in 1% osmium tetroxide,
they were then dehydrated, Epon embedded and ultrathin
sectioned on a Leica Ultracut. Sections were stained in uranyl
acetate and lead citrate, and observed in a Philips EM 400 trans-
mission electron microscope.
In situ hybridization (ISH)
Tissue samples were embedded in Tissue-Tek OCT compound
(Miles, Elkhart, IN) and snap-frozen in liquid nitrogen. Frozen
blocks were stored at -80°C until used. Tissue sections (5 jim)
were cut on a cryostat (Microm, Heidelberg, Germany) and
adhered to silanized glass slides.
Riboprobes were designed complementary to a fragment of the
cytoplasmic part of human EGFR (400bp) based on published
reports of the cDNA sequence. The specificity of the probe was
checked using the Genetics Computer Group sequence analysis
software package (GCG, Madison, WI, USA). Total RNA was
extracted from Caco-2 cells. cDNA was obtained by standard
reverse transcriptase reaction using random primers. The next
specific primers were designed 5'-CATTCAGGGGGATGAAAG-
3' and 3'-GGACAGATAGTGAGTCGG-5' for EGFR. Hot-start
PCR was performed on a GeneAmp PCR System 9600 (Perkin
Elmer, Foster City, CA, USA). Amplification products were ligated
to a pCRII vector (Invitrogen, San Diego, CA, USA). The orienta-
tion ofinserts was checked by PCR using different combinations of
external and internal primers and by digestion with appropriate
restriction enzymes. Recombinant plasmid DNA was extracted
using a plasmid midi kit (Qiagen, Hilden, Germany) and was
linearized by HindIll, Notl restriction enzymes (New England
Biolabs, Beverly, MA, USA). The antisense and sense probes were
synthesized by transcription in vitro reaction with digoxigenin- 11-
UTP (Boehringer, Mannheim, Germany) and SP6, or T7 RNA
polymerases (Promega, Madison, WI, USA). The molecular weight
of the riboprobes was checked on agarose gels. The concentration
of the probe was determined by serial dilution on a dot-blot using
nylon membranes (Amersham, Buckinghamshire, UK).
Cryocut tissue sections were fixed for 3 h in freshly prepared 4%
formaldehyde in phosphate-buffered saline (PBS). Endogenous
alkaline phosphatase was blocked by 0.2 N hydrochloric acid.
Subsequently, cells were treated with proteinase K for 6-8 min at
37°C. After denaturation, probes were suspended in a hybridization
solution with 50% formamide and were used for hybridization at
50°C overnight. Sections were washed, blocked with 1.5% normal
goat serum and incubated with anti-digoxigenin-alkaline phos-
phatase antibody (Boehringer Mannheim, Germany) for 1 h at
room temperature. The BCIP/NBT substrate IV kit (Vector Labs,
Burlingame, CA) was used to localize alkaline phosphatase
activity. Cells were counterstained with methyl green.
Cell lines
The human colon adenocarcinoma-derived cell line Caco-2 grows
in a 'tight' monolayer after confluency but displays remarkable
heterogeneity in growth and differentiated characteristics (see
Beaulieu and Quaroni, 1991). Therefore, two Caco-2 cell clones,
which were analysed for their proliferative potential and for their
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Figure 1 Microscopy of primary cultures used in subsequent in vitro studies. (A) Phase-contrast image of primary colon epithelial cell outgrowth from an
organoid after 2 days of culture (x80). (B) Light microscopy of primary cells from a moderately differentiated rectal adenocarcinoma (passage 3, x80). (C) TEM
of highly polarized primary epithelial cells (x6000). (D) TEM of highly polarized primary epithelial cells with desmosomes (arrow) and microvilli (x12 000).
(E) Expression and organization of cytokeratin 8 (x480). (F) cytokeratin 18 (x480)
degree ofdifferentiation, were used in the present study in parallel
to primary cultures: the clone Caco-2/15 was obtained from Dr A
Quaroni, Cornell University, NY From this cell line we isolated
the subclone Caco-2/AQ by dilution plating after passage 100. The
population doubling time of Caco-2/AQ during the logarithmic
growth phase was estimated as 24 h vs 36 h ofthe Caco-2/15 clone
(see Beaulieu and Quaroni, 1991). The activity of the differentia-
tion marker alkaline phosphatase increased during 20 days of
confluent growth from an average of20 to 60 mU per mg cellular
protein in Caco-2/AQ, whereas the corresponding values for the
parent clone Caco-2/15 were 25 and 190 mU per mg protein.
I1251]EGF binding assay
Primary cultured cells and cell lines were plated on Transwell poly-
carbonate membranes (24.5 mm diameter, 4.71 cm2 surface area,
and 0.4 gm pore size). Medium was changed (1.5 ml inside and 2.6
ml outside) two to three times a week. One week after confluency,
cells were used for binding studies of ['251]EGF to apical or basolat-
eral plasma membranes according to a method used by Hidalgo et al
(1989). Briefly, cell monolayers were washed three times with ice-
cold serum-free DMEM, and ['251]EGF (mouse [1251]EGF, sp. act.
100 ,Ci mg-', Amersham, Buckinghamshire, UK) binding was
determined in 2 ml of binding medium (DMEM plus 0.1% bovine
serum albumin). ['25I]EGF (0.5 ng ml-') was applied for 3 h at 4°C
on either the apical or the basolateral side, with only binding
medium at the opposite chamber. Non-specific binding was deter-
mined in the presence of 100-fold excess unlabelled EGF. Atthe end
of the incubation, monolayers were rinsed in ice-cold binding
medium, trypsinized and counted in an Automatic Gamma Counter
(1277 GammaMaster, LKB). Protein was evaluated using the BCA
kit. Bound [125I]EGF, or the amount of receptor, was expressed as
fmol mg-' protein.
Cell proliferation assay
DNA synthesis was assessed by measuring incorporation of
[3H]thymidine into cellular DNA. Cultures were incubated with
4gCi mll of [3H]thymidine (70 Ci mmol-', American Radiolabeled
Chemicals, St Louis, USA) for 6 h and were extracted twice with
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5% trichloroacetic acid. After solubilization in 1 ml of 0.1 mol 1-'
sodium hydroxide, extracts were counted for radioactivity in a
Wallac 1410 Liquid Scintillation Counter (Pharmacia). Total protein
content of the samples was determined with the BCA kit. Results
were expressed as c.p.m. jig-' protein.
RESULTS
Primary cultures
A total of27 primary cultures were obtained from colorectal tissue
derived from 45 patients. The most common histopathological
class of colorectal adenocarcinomas, which accounts for three-
quarters ofthese patients, is the moderately differentiated one. No
correlation was observed between the histological grade of the
tumour and the growth behaviour of tumour cells in vitro. In all
successful cultures, growth was evident within 7 days ofinitiation.
Phase-contrast microscopy showed that all cells grew as mono-
layers with varying efficiency of attachment to the plastic
substrate or glass coverslips (Figure 1A and B). In some cultures,
cells had migrated from the organoids within 24 h to form a flat
monolayer with typical epithelial appearance andlarge pale nuclei.
Primary cells were polarized with basally located nuclei, apically
located Golgi apparatus and numerous microvilli on the apical
surface (Figure IC). Junctional complexes as well as microvilli
indicate polarity of cells (Figure ID). By intermediate filament
typing using antibodies directed against cytokeratin subtypes 8
and 18, we further characterized the uniformity of the epithelial
cells in our cultures (Figure IE and F).
Some primary cells could be subcultured within 1-3 months
after initiation. Primary cells, PC52 derived from a rectal carci-
noma (Dukes' stage B) and PC53 derived from a colon carcinoma
(Dukes' stage C), were used in subsequent [1251]EGF-binding
assays and proliferation experiments between passages 3 and 6. At
that time, the epithelial nature of passaged cells was determined
again with cytokeratin staining and with TEM.
EGFR mRNA expression in tumour tissue
Using the ISH method, we wanted to verify EGFR mRNA distrib-
ution in human colon tissue during cancer progression. In all five
tumour samples inspected, regardless oftheir degree ofdifferenti-
ation, there was always conspicuously more EGFR expression in
epithelial cells from cancerous tissue than in those from the adja-
cent normal mucosa outside the tumour border from the same
patient. A representative example for this distribution pattern is
presented in Figure 2B and C. Figure 2A shows the negative
control in this particular tissue.
EGFR polarity in colorectal cancer cells
EGFR levels were evaluated from the extent of specific [1251I]EGF
binding to the apical and basolateral surface of colorectal carci-
noma cells cultured on semipermeable filters (Table 1). In the two
subclones derived from the Caco-2 cell line (2/15, 2/AQ), EGFRs
were mainly located at the basolateral cell site. There was no
difference in site distribution or of total numbers of ['25I]EGF-
binding sites between the two Caco-2 cell clones.
EGF treatment of Caco-2/15 cells resulted in significant down-
regulation of the receptor at the basolateral membrane but only
marginally at the apical side. In Caco-2/AQ cells EGF treatment
A
B
C
Figure 2 In situ hybridization of EGFR mRNA in human colon tissue
(representative sample from one patient out of five). (A) Negative control.
(B) EGFR mRNA expression in normal adjacent mucosa (arrow). (C) EGFR
mRNA in primary cancer tissue (Dukes' stage B). Arrow, positive staining of
EGFR mRNA (x75)
significantly reduced basolateral receptors, but increased apical
ones, although only slightly.
PC52 and PC53 primary cells each exhibited a comparable
average amount oftotal EGFR, which was, however, almost three
times higher than in the two Caco-2 clones investigated. In addi-
tion, primary culture PC52 and 53 cells, quite in contrast to the
Caco-2 cells, exhibited three- to fivefold higher EGFR density on
their apical than on their basolateral side.
Scatchard analysis of apical EGF binding demonstrates a linear
relationship with acalculated dissociation constantof0.256 nmol 1-'
and 0.260 nmol 1-1 for PC52 and PC53, respectively, indicating the
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Figure 3 Displacement of ['251]EGF by unlabelled EGF and Scatchard plot
analysis. Cell monolayers were incubated with 0.5 ng ml-' ['251]EGF, on the
apical side only, and in the presence of 1-500 ng mi-' unlabelled EGF
(A, PC52 cells; B, PC53 cells)
presence of a single class of high-affinity receptors localized on
apical membranes ofbothprimary culture clones (Figure 3A and B).
EGF treatment of PC52 and 53 cells resulted in a decrease in
['251]EGF-binding sites on both the apical and basolateral
membrane, whereby the relative extent to which reduction of
receptor density occurred at the latter site, was much higherthan in
the Caco-2 clones (see Table 1).
Cell proliferation
Table 2 illustrates results of [3H]thymidine incorporation into
cellular DNA in Caco-2 clones as well as in PC52 and in PC53
primary cells. Treatment of Caco-2/15 cells with 25 ng ml-' EGF
doubles [3H]thymidine incorporation when the growth factor was
added to the apical side, and quadruples it after stimulation of
basolateral receptors. In contrast, Caco-2/AQ cells do not respond
to EGF treatment, neither apically nor basolaterally.
In primary cells, proliferation before EGF treatment is generally
higher than in the Caco-2 cell clones investigated. This is particu-
larly valid when PC52 and PC53 cells are compared with the
Table 1 Radioligand assay of EGFR in Caco-2 clones and in primary
cultures
[1251]EGF bound
Cells Control EGF
Apical Basolateral Apical Basolateral
Caco-2/15 461 ± 44 2920 ± 88 354± 16 159± 16
Caco-2/AQ 470 ± 29 3152 ± 52 700 ± 14 418± 33
PC52 5937 ±457 1249 ± 67 185 ± 16 33± 11
PC53 7748± 91 2443± 110 229 ± 16 55± 17
Data are expressed as means + s.d. (fmol mg-' protein); n = 6 from two
- __t separate experiments. Cell were grown on Transwell filter plates. After
400 500 2 days' confluency, 25 ng ml-' EGF was added at the apical or basolateral
sides.
Table 2 [3H]thymidine incorporation into cellular DNA in Caco-2 clones and
in primary cultured cells
Cells Apical Basolateral
Control EGF Control EGF
Caco-2/15 62 ± 3 175± 18* 85 ± 6 411 ± 18*
Caco-2/AQ 72±6 73+8 228±9 216±8
PC52 417± 17 968± 74* 261 ± 14 778± 110*
PC53 554 ± 7 854± 58* 265 ± 7 598± 19*
Data are presented as means ± s.d. (c.p.m. ,ug-' protein); n = 6 from two
separate tests. Caco-2/15, 2/AQ, as well as PC52 and PC53 primary cells
were grown on Transwell filters. After 2 days' confluency, 25 ng ml-' EGF
was added at the apical or basolateral sides. *P < 0.01 compared with
control.
rather well-differentiated Caco-2/15 cells, which show only one-
sixth to one-third of the proliferative potential of the primary
culture cells (Table 1). EGF-treated primary culture PC52 and
PC53 cells exhibit an approximately twofold increase in the extent
of[3H]thymidine labelling ofDNA when compared with untreated
controls, regardless of whether they were exposed to EGF at their
apical or basolateral side.
When data collated in Tables 1 and 2 are compared, it becomes
obvious that, although in EGF-sensitive Caco-2/15 cells more than
80% ofthe receptors are located basolaterally, and in PC52 and 53
cells an even higher percentage of EGFR is found on the apical
side, EGF stimulation of DNA synthesis via apical or basolateral
receptors was roughly equal in each cell type. This indicates a
partial impairment of EGFR signalling from the apical surface in
primary cultures or from the basolateral side in Caco-2/15 cells.
DISCUSSION
In the present study, distribution of EGFR on polarized cell
membranes and its possible role in colon tumorigenesis was investi-
gated. Using ISH methods, we and others (see Radinsky et al, 1993)
were able to show that increasingly higher expression of EGFR
mRNA is found during colon tumour progression. When compared
with colon tissue from the same patient, but outside the tumour
border, this difference becomes very apparent. As a representative
example (out of five) we demonstrate EGFR mRNA in a Dukes'
stage B tumour and in adjacent 'normal' mucosa in Figure 2. As
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established cell lines, such as Caco-2 or HT-29, go through a selec-
tion process during passaging because ofgenetic instability and thus
are frequently changed when compared with the in vivo situation,
we wanted to gain insight into mechanisms of growth control of
human colorectal carcinomas by using primary cultured cells.
For reproducible establishment of cultures we used organoids
obtained by mechanical orenzymatic dissociation. When provided
with appropriate nutrients and feeder support, these attach to glass
coverslips and give rise to epithelial colonies, which can be
subcultured and maintained for a period of months. Owing to this
method of organoid isolation, and selective cultivation on glass
coverslips in Petri dishes where 3T3 feeder cells are present,
fibroblast contamination and overgrowth of epithelial cells was
rarely a problem. Subsequent passaging from the coverslips by
mechanical isolation resulted in sufficient cells to establish tight
monolayers on filters. This enabled us to study EGFR distribution
at apical and basolateral cell sides.
EGFR distribution on enterocytes in the adult human gastro-
intestinal tract is restricted to basolateral plasma membranes
(Playford et al, 1995). Caco-2 cells, which have retained the ability
to spontaneously differentiate during post-confluent growth in a
manner similar to normal enterocytes, display EGFR predomi-
nantly at their basolateral side (Table 1). EGFR polarity in Caco-2
cells (see also Hidalgo et al, 1989; Cross and Quaroni, 1991;
Bishop and Wen, 1994) is thus reminiscent to that in the normal
human gut, where systemic EGF mediates proliferation via baso-
lateral receptors. In the human fetal colon, however, EGFR is
strongly expressed apically only. This suggests that in the human
fetus and neonate luminal EGF available via secretion from
Brunner's glands or via mother's milk could be of relevance in
mediating proliferation and maturation in the gut (Menard et al,
1988). The observed EGFR shift from the basolateral to the apical
compartment in two polar primary cancer PC52 and PC53 cells
(Table 1) thus reflects a pattern of EGFR distribution observed in
the human fetal colon (see Menard et al, 1988). Although only 2
from 27 originally isolated primary cultures could be used because
of the difficulty to obtain 'tight' primary cultures and, hence, our
results may thus not be wholly representative, we nevertheless
would like to suggest that redistribution ofEGFR density is not an
unlikely event during colon tumour progression and that it might
thus represent another example of typical oncofetal development
in colon cancer.
When compared with two Caco-2 cell clones, EGFR density in
primary cells PC52 and PC53 is at least three times as high.
However, whereas in Caco-2 cells only 10-20% oftotal receptors
are located apically, this relationship is switched in primary carci-
noma cells so that more than 80% of EGFRs are located at
the apical side (Table 1). The single population of receptors
at the apical side of both PC52 and PC53 cells has an apparent
Kd of 0.26 nmol 1-', which is comparable with that of the major
high affinity EGFR of Caco-2 cells with an apparent Kd of
0.67 nmol 1- (Hidalgo et al, 1989).
In contrast to the relative abundance of ['251]EGF-binding sites
on the apical over the basolateral membrane in PC52 and PC53
cells, mitogenic EGF signals are transduced with an approxi-
mately equal efficiency across either the apical or the basolateral
membrane. The same phenomenon is observed in Caco-2/15 cells,
except that receptor polarity is reversed in these cells compared
with primary culture cells (see Tables 1 and 2). It must therefore be
assumed that a part of apical EGFR in primary culture cells or of
basolateral EGFR in Caco-2/15 cells is non-functional, i.e. is
unable to transduce signals from the ligand-occupied receptor
because of structural alterations outside the ligand-binding
domain. Another explanation for the apparent dissociation of
receptor density from efficiency of signal transduction could be
derived from the observation that exposure to EGF significantly
reduced the number of ['251]EGF-binding sites on the apical and,
particularly, on the basolateral membranes of the colon cancer
cells studied (Table 1). Thus, rapid down-regulation of EGFR
numbers through internalization of the ligand-receptor complex,
as has been also observed by Hidalgo et al (1989), must inevitably
reduce the availability offunctional membrane receptors for EGF.
Bishop and Wen (1994) had suggested that in the original Caco-
2 cell line proliferation is driven exclusively by ligand-activated
basolateral membrane EGFR, whereas in the present study
Caco-2/15 cells responded to both apical and basolateral EGF
stimulation (Table 2). As Bishop and Wen studied Caco-2 cell
proliferation only in the 1-5 ng ml-' EGF concentration range, it
remains to be seen whether Caco-2 cells would not respond to the
25 ng ml-' EGF concentration used in the present study. Ifnot, one
should consider the possibility that in the heterogeneous Caco-2
cell line the great majority of cells lacks any sensitivity to apical
membrane EGFR activation, whereas, e.g., cells that are
completely insensitive to EGF, such as the subclone Caco-2/AQ
(Table 2) or that, similar to the Caco-2/15 clone, are responsive to
both basolateral and apical membrane receptor activation (Table
2), represent only minor fractions in the parental Caco-2 cell line.
In conclusion, we would like to suggest that the characteristic
oncofetal abundance of EGFR at the apical, i.e. luminal, cell
membrane during tumour progression could convey increased
sensitivity to colon tumour cells to mitogenic stimulation by
growth factors contained in or secreted into the gut lumen and may
thus play an important part in the development of colorectal
cancer.
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